Stocktoria

MACROGENICS INC MGNX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2013-10-10 · LEI

MACROGENICS INC financials (annual)

Revenue
$91.9M $157.7M $60.1M $64.2M $104.9M $77.4M $151.9M $58.7M $150.0M $149.5M 2016201720182019202020212022202320242025
Net income
-$58.5M -$19.6M -$171.5M -$151.8M -$129.7M -$202.1M -$119.8M -$9.1M -$67.0M -$74.6M 2016201720182019202020212022202320242025
Free cash flow
-$55.1M -$15.0M -$178.2M -$138.6M -$117.8M -$150.0M -$90.6M -$80.0M -$72.1M -$83.0M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$149.5M$150.0M$58.7M$151.9M$77.4M$104.9M$64.2M$60.1M$157.7M$91.9M
R&D expense$147.2M$177.2M$166.6M$207.0M$214.6M$193.2M$195.3M$190.8M$147.2M$122.1M
Operating income-$72.8M-$110.6M-$168.2M-$121.4M-$202.8M-$131.1M-$177.2M-$171.2M-$22.1M-$60.0M
Interest expense$1.1M$1.4M$0$0
Income tax-$672,000$944,000$0$0$0$0$0$0$0$0
Net income-$74.6M-$67.0M-$9.1M-$119.8M-$202.1M-$129.7M-$151.8M-$171.5M-$19.6M-$58.5M
EPS (diluted)$-1.18$-1.07$-0.15$-1.95$-3.37$-2.47
Operating cash flow-$81.0M-$68.4M-$78.2M-$87.0M-$143.8M-$111.9M-$134.3M-$153.2M$14.4M-$43.7M
Free cash flow-$83.0M-$72.1M-$80.0M-$90.6M-$150.0M-$117.8M-$138.6M-$178.2M-$15.0M-$55.1M
Cash & equivalents$57.2M$182.8M$101.0M$108.9M$123.5M$181.1M$126.5M$220.1M$211.7M$84.1M
Inventory$7.9M$0$1.2M$1.5M$4.4M$0
Total assets$256.8M$261.7M$298.4M$280.5M$335.2M$378.7M$312.5M$332.1M$373.9M$311.3M
Total liabilities$201.3M$145.6M$145.8M$138.5M$95.6M$82.9M$81.9M$89.3M$74.6M$42.5M
Shareholders' equity$55.6M$116.1M$152.6M$142.0M$239.6M$295.9M$230.6M$242.9M$299.2M$268.8M

Growth · year-over-year · Revenue CAGR 5.6%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth-0.3%+155.3%-61.3%+96.2%-26.2%+63.4%+6.8%-61.9%+71.7%-8.9%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.